Jul 2018 Adenosine Pathway Modulation via A2AR, CD39 & CD73 – Target Pipeline List 07/2018 100.00 €
Jul 2018 Competitor Analysis: CD40, GITR, OX40, 4-1BB, CD27, ICOS & Other Immune Checkpoint Activators 2018 500.00 €
Jun 2018 Competitor Analysis: CTLA-4, LAG-3, TIM-3, TIGIT & Other Immune Checkpoint Inhibitors 2018 500.00 €
Jun 2018 Report Package: Immunotherapeutics Targeting MAGE-A, NY-ESO-1, hTERT, WT1, PRAME and Survivin 810.00 € 1,350.00 €(Discount: 40.00%)